|

JANX008 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Janux Therapeutics1

Indications

  • Squamous Cell Carcinoma of the Head and Neck1
  • Renal Cell Carcinoma1
  • Pancreatic Ductal Adenocarcinoma1
  • Colorectal Carcinoma1
  • Triple Negative Breast Cancer1

Duarte, California1 trial

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

City of Hope Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.